B. Scott Segal to Multiple Sclerosis, Relapsing-Remitting
This is a "connection" page, showing publications B. Scott Segal has written about Multiple Sclerosis, Relapsing-Remitting.
Connection Strength
0.544
-
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 2008 Sep; 7(9):796-804.
Score: 0.319
-
Huber AK, Wang L, Han P, Zhang X, Ekholm S, Srinivasan A, Irani DN, Segal BM. Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS. Neurology. 2014 Oct 21; 83(17):1500-7.
Score: 0.121
-
Braley TJ, Lee YH, Mohan S, Segal BM, Berini S, Srinivasan A. Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions. J Comput Assist Tomogr. 2012 Jul-Aug; 36(4):410-5.
Score: 0.104